20 Questions to Ask Before Starting Peptide Therapy
Understanding Peptide Therapy: Essential Questions Before You Begin
Peptide therapy represents one of the fastest-growing areas in regenerative and functional medicine, yet it remains one of the least regulated and most poorly understood by patients considering it. As therapeutic peptides move from research laboratories into clinical practice—through both FDA-approved channels and compounded formulations—the stakes for informed decision-making have never been higher. Before initiating any peptide therapy, you should understand not only what you're being given, but also the evidence supporting its use, who is administering it, and what happens if something goes wrong.
This guide presents twenty critical questions organized across five essential domains: your provider's qualifications, the specific peptide's evidence base, pharmacy quality and sourcing, your personalized monitoring plan, and financial considerations. These questions serve as a framework for evaluating whether peptide therapy is appropriate for your situation and whether you're receiving it under optimal conditions.
Questions About Your Provider and Clinic
Provider Credentials and Experience
Your first line of inquiry should address who is recommending peptide therapy and what qualifies them to do so. Ask whether your provider holds an active medical license (MD, DO, NP, or PA as applicable in your jurisdiction) and whether they have specific training or certification in peptide use. This matters because peptide pharmacology differs substantially from traditional pharmaceuticals, and not all licensed practitioners understand these distinctions. Inquire how many patients they have treated with the specific peptide you're considering and over what timeframe. A provider administering peptides for six months has less practical experience than one with five years of cases. Ask whether they maintain any published research, case reports, or continuing education credentials specifically related to peptide therapy.
Understanding the clinic's oversight structure is equally important. Ask whether peptide therapy is being provided under the direct supervision of a physician, or whether your care is being coordinated with a primary care physician who can monitor for adverse effects. Ask specifically whether your provider maintains malpractice insurance and whether the clinic has experience handling adverse events related to peptide therapy. This reveals whether the clinic takes liability seriously and has protocols for managing complications.
Questions About the Specific Peptide
Evidence Base and Clinical Status
Your understanding of what peptide you're receiving and why should begin with clarity about its regulatory status. Ask whether the peptide is FDA-approved for your specific indication, or whether it is being used off-label or in a compounded form. These distinctions matter enormously. An FDA-approved peptide like semaglutide for type 2 diabetes has undergone rigorous clinical trials in thousands of patients. A compounded version of the same peptide may have comparable molecular structure, but lacks the same manufacturing oversight and clinical data supporting its safety and efficacy for your particular use.
Ask your provider what human clinical evidence supports using this peptide for your specific condition. There's a meaningful difference between "animal studies show promise," "small human case series exist," and "multiple randomized controlled trials demonstrate efficacy." Many peptides currently in clinical use have strong preclinical data but limited human trial data. BPC-157, for example, shows substantial promise in animal models for tissue repair, but human clinical trials remain limited. This is not necessarily a reason to avoid such peptides, but it is essential information for informed consent.
Request information about the peptide's half-life, mechanism of action, and how long benefits typically persist. Ask whether you should expect immediate effects or whether therapeutic benefits develop over weeks or months. Understanding the pharmacokinetics helps you establish realistic expectations and recognize whether the therapy is working as intended during your treatment course.
Contraindications and Interactions
Ask your provider whether this peptide interacts with your current medications, supplements, or medical conditions. Peptide interactions are sometimes less well-characterized than traditional drug interactions because peptide therapy is newer. Ask specifically whether the peptide is contraindicated in anyone with your medical history—whether active malignancy, cardiovascular conditions, or metabolic disorders might make peptide therapy inadvisable in your case. Some peptides that promote cell growth or angiogenesis raise theoretical concerns in cancer patients, even if direct evidence is limited.
Questions About Pharmacy Quality and Sourcing
Manufacturing Standards and Testing
Where your peptide is manufactured and how it's tested directly impacts safety and efficacy. Ask whether your peptide is being compounded by a 503A compounding pharmacy (typically serving individual patients) or a 503B outsourcing facility (serving multiple facilities). Ask what quality control testing is performed on the final compounded product. Legitimate compounding pharmacies should verify peptide identity through HPLC (high-performance liquid chromatography) and assess purity levels. Ask whether the pharmacy tests for bacterial endotoxins and sterility—essential for injectable peptides.
Request information about your pharmacy's compliance history with state and federal pharmacy boards. Ask whether the pharmacy has ever been subject to FDA warning letters or enforcement actions. The FDA has sent warning letters to compounders making unsubstantiated claims about peptide products, which suggests broader quality issues. Request the lot number of your peptide and ask whether it's traceable back to the manufacturer.
Questions About Your Personalized Monitoring Plan
Assessment Protocols and Follow-up
Ask your provider specifically how treatment efficacy will be measured. Will you use validated questionnaires, laboratory markers, imaging studies, or clinical assessment? Vague statements about "feeling better" are not adequate monitoring for peptide therapy. Ask how frequently you'll be evaluated and what specific findings would prompt discontinuation of therapy. Ask whether baseline laboratory work will be performed before starting therapy and whether specific labs will be monitored during treatment.
Inquire about what adverse effects to expect and how they should be reported. Ask whether your provider has a protocol for managing side effects and whether you'll have access to care if problems develop outside regular clinic hours. Ask whether your provider will maintain records of your peptide therapy that you can access and share with other healthcare providers.
Questions About Cost and Access
Financial Responsibility and Insurance
Ask explicitly whether your insurance covers this peptide therapy, and if not, what your out-of-pocket costs will be. Ask whether pricing includes follow-up visits and monitoring, or whether those are billed separately. Ask about refund or adjustment policies if the therapy proves ineffective or intolerable. Understanding the full financial commitment helps prevent situations where patients discontinue necessary monitoring due to unexpected costs.
By asking these twenty questions systematically, you create a comprehensive picture of whether peptide therapy is appropriate for you and whether you're receiving it under conditions that maximize safety and efficacy.